ANTIMICROBIAL RESISTANCE PROFILES AND CARBAPENEMASE PRODUCTION IN KLEBSIELLA PNEUMONIAE ISOLATES AT CAN THO GENERAL HOSPITAL, 2024 - 2025
Main Article Content
Abstract
Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major threat to hospital infection control and clinical treatment. The increasing prevalence of carbapenemase producing strains not only undermines the effectiveness of carbapenems - the “last line of defense” antibiotics, but also complicates therapeutic decision making and increases the healthcare burden. Objectives: 1. To determine the prevalence of carbapenemase-producing Klebsiella pneumoniae and associated factors. 2. To determine the antibiotic resistance rates of Klebsiella pneumoniae strains. Materials and methods: A total of 57 Klebsiella pneumoniae isolates were collected, identified, and subjected to antimicrobial susceptibility testing using an automated system. Carbapenemase production was detected by the modified carbapenem inactivation method (mCIM), and associated factors were analyzed. Results: The prevalence of carbapenemase production among CRKP isolates was 63.2% (36/57). Carbapenemase production was significantly associated with male gender (p = 0.043) and sputum specimens (p = 0.020). The CRKP group exhibited absolute resistance (100%) to ampicillin and cefotaxime, along with extremely high resistance (> 86%) to carbapenems and fluoroquinolones. The resistance rates in the CRKP group were significantly higher than those in the non-CRKP group for most of the tested antibiotics (p < 0.001). Conclusions: Carbapenemase-producing Klebsiella pneumoniae strains demonstrated extremely high antibiotic resistance rates, underscoring the urgent need for enhanced surveillance, strict infection control measures, and rational antibiotic use to limit the spread of multidrug-resistant pathogens.
Keywords
Klebsiella pneumoniae, CPKP, antimicrobial resistance, carbapenemase
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Wyres K.L., Nguyen T.N.T., Lam M.M.C., et al. Genomic surveillance for hypervirulence and multidrug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Medicine. 2020. 12(11), 11. doi: 10.1186/s13073-019-0706-y.
3. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization. 2017. 5-7.
4. Moradigaravand D., Martin V., Peacock S.J., and Parkhill J. Evolution and epidemiology of multidrug-resistant Klebsiella pneumoniae in the United Kingdom and Ireland. mBio. 2017. 8(e01976-16), doi: 10.1128/mBio.01976-16.
5. Carmeli Y., Akova M., Cornaglia G., Daikos G.L., Garau J., et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clinical Microbiology and Infection. 2010. 16(2), 102-111, doi: 10.1111/j.14690691.2009.03115.x.
6. Hu F., Pan Y., et al. Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multicentre study. Nature Microbiology. 2024. 9, 814-829, doi: 10.1038/s41564-024-01612-1.
7. Nguyễn Đức Quỳnh, Trần Thị Phương, và cộng sự. Một số đặc điểm kháng kháng sinh và yếu tố nguy cơ nhiễm khuẩn bệnh viện do Klebsiella pneumoniae kháng carbapenem tại Khoa Hồi sức tích cực - Bệnh viện Bạch Mai (2019-2020). Tạp chí Y học Việt Nam. 2021. 502(1), 35-42.
8. Wang Q., Wang X., Wang J., Ouyang P., Jin C., et al. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). Clinical Infectious Diseases. 2018. 67(suppl_2), S196-S205, doi: 10.1093/cid/ciy660.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; M100-S30. Clinical and Laboratory Standards Institute. 2020. 118-130.
10. Biomerieux. VITEK 2 Compact Instrument User Manual. Biomerieux. 2009.
11. Trần Phú Vinh, Dương Xuân Chữ, Nguyễn Thị Diệu Hiền, Lâm Nhân Hậu. Nghiên cứu tình hình đa kháng kháng sinh của Klebsiella pneumoniae sinh ESBL, carbapenemase tại Bệnh viện Đa khoa Trung ương Cần Thơ. Tạp chí Y học Việt Nam. 2022. 516(1), 78-82, doi: 10.51298/vmj.v516i1.2957.
12. Lê Công Trứ, Đỗ Hoàng Long, Trần Đỗ Hùng. Tình hình đề kháng kháng sinh của Klebsiella pneumoniae tại Bệnh viện Đa khoa Trung ương Cần Thơ. Tạp chí Y học Việt Nam. 2022. 518(2), doi: 10.51298/vmj.v518i2.3492.